This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
One week after Agilent Technologies completed its $250 million acquisition of Stratagene, a company official said that he expects Stratagene’s molecular diagnostic collaborations to remain on track and that Agilent will be in close contact with those partners.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.